We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Miltenyi Biotec Acquires Owl Biomedical, Inc.

News   Apr 29, 2013

 
Miltenyi Biotec Acquires Owl Biomedical, Inc.
 
 
 

RELATED ARTICLES

From Fibroblast to Antigen-presenting Dendritic Cell: a Pioneering Approach

News

Direct programming of mouse and human skin cells into antigen-presenting dendritic cells opens up the possibility of developing novel dendritic cell-based immunotherapies against cancer.

READ MORE

Immune System on a Chip Launched to Space

News

Research on the ISS National Lab is creating unprecedented opportunities for scientists to study microgravity-induced changes in human physiology relevant to diseases here on Earth, and accelerates the development of translational technologies for earthly applications.

READ MORE

Emerging Evidence for the Pancreatic Progenitor Cell Hypothesis

News

A contentious debate among diabetes researchers has surrounded the regeneration of pancreatic insulin-producing cells: not if these cells regenerate, but rather how.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE